Pharming Group N.V.
Prognozy (mln)
| Okres |
2024-12-31 |
2025-12-31 |
2026-12-31 |
2027-12-31 |
2028-12-31 |
2029-12-31 |
| Przychód (średnia) |
286.40 |
340.31 |
356.63 |
392.15 |
334.89 |
381.86 |
| Przychód Δ r/r |
0.00% |
18.82% |
4.79% |
9.96% |
-14.60% |
14.03% |
| Przychód (min) |
284.52 |
327.32 |
325.87 |
373.45 |
318.92 |
363.65 |
| Przychód (max) |
288.74 |
357.82 |
390.16 |
413.63 |
353.23 |
402.78 |
| EBITDA (średnia) |
52.61 |
62.51 |
65.51 |
72.04 |
61.52 |
70.15 |
| EBIT (średnia) |
34.12 |
40.54 |
42.49 |
46.72 |
39.90 |
45.49 |
| EBIT % |
11.91% |
11.91% |
11.91% |
11.91% |
11.91% |
11.91% |
| Zysk netto (średni) |
-7.93 |
-3.74 |
0.04 |
5.52 |
4.01 |
6.02 |
| Zysk netto % |
-2.77% |
-1.10% |
0.01% |
1.41% |
1.20% |
1.58% |
| EPS (średnia) |
-0.12 |
-0.05 |
0.00 |
0.08 |
0.06 |
0.09 |
| Liczba analityków (Przychody) |
4 |
2 |
5 |
2 |
1 |
2 |
| Liczba analityków (EPS) |
2 |
2 |
2 |
1 |
1 |
1 |
| symbol |
PHAR |
PHAR |
PHAR |
PHAR |
PHAR |
PHAR |